CRISPR Helps BRCA1 Researchers Determine Functional And Non-Functional Mutations
BRCA1 variants may generally be divided into three categories: benign variants, which cause no...
News | June 29, 2023
Devyser launches two new genetic testing solutions for hereditary cancer
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2. These kits offer efficient, targeted, and confident analysis of genes associated with...
Find out more
